Oncternal Therapeutics ONCT

Quarterly report 2024-Q3
added 11-06-2024

Oncternal Therapeutics DIO Ratio 2011-2026 | ONCT

Annual DIO Ratio Oncternal Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	-	55.7

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
55.7	55.7	55.7

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Amgen AMGN	200	$ 345.82	1.71 %	$ 186 B	USA
	Amneal Pharmaceuticals AMRX	117	$ 12.61	2.35 %	$ 3.95 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Arcutis Biotherapeutics ARQT	185	$ 24.35	4.64 %	$ 3.1 B	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Autolus Therapeutics plc AUTL	70.7	$ 1.44	5.51 %	$ 383 M	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Aytu BioScience AYTU	209	$ 2.74	6.42 %	$ 17.2 M	USA
	Avid Bioservices CDMO	102	-	-	$ 789 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Cerus Corporation CERS	213	$ 1.94	5.43 %	$ 370 M	USA
	CTI BioPharma Corp. CTIC	38.1	-	-	$ 1.2 B	USA
	Cyclacel Pharmaceuticals CYCCP	185	-	-4.36 %	$ 27 M	USA
	Deciphera Pharmaceuticals DCPH	2.04 K	-	-	$ 2.18 B	USA
	Dynavax Technologies Corporation DVAX	455	-	-	$ 2.02 B	USA
	Coherus BioSciences CHRS	97.5	$ 1.68	0.6 %	$ 197 M	USA